Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and cantharidin

2-chloro-n(6)cyclopentyladenosine has been researched along with cantharidin in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(cantharidin)
Trials
(cantharidin)
Recent Studies (post-2010) (cantharidin)
25204387527307

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)cantharidin (IC50)
Protein phosphatase 1BHomo sapiens (human)1.78
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)3.6
Serine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)1.78
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B Gallus gallus (chicken)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lasley, RD; Mentzer, RM; Narayan, P1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and cantharidin

ArticleYear
Phosphatase inhibitor cantharidin blocks adenosine A(1) receptor anti-adrenergic effect in rat cardiac myocytes.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adrenergic beta-Agonists; Animals; Calcium; Cantharidin; Cyclic AMP; Enzyme Inhibitors; Intracellular Membranes; Isoproterenol; Male; Myocardial Contraction; Myocardium; Phosphoric Monoester Hydrolases; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1

2000